SLC44A2 (solute carrier family 44 member 2 (CTL2 blood group))
Gene | |
Entrez ID
Entrez Gene ID - the GENE ID in NCBI Gene database.
|
57153 |
Gene name
Gene Name - the full gene name approved by the HGNC.
|
Solute carrier family 44 member 2 (CTL2 blood group) |
Gene symbol
Gene Symbol - the official gene symbol approved by the HGNC.
|
SLC44A2 |
Synonyms (NCBI Gene)
Gene synonyms aliases
|
CTL2, PP1292 |
Chromosome
Chromosome number
|
19 |
Chromosome location
Chromosomal Location - indicates the cytogenetic location of the gene or region on the chromosome.
|
19p13.2 |
miRNA
miRNA information provided by mirtarbase database.
|
|||||||||||||||||||||||||
|
Gene ontology (GO)
Gene ontology information of associated ontologies with gene provided by GO database.
|
|||||||||||||||||||||||||||||||
|
Other IDs
Other ids provides unique ids of gene in databases such as OMIM, HGNC, ENSEMBLE.
|
|||||||
|
Protein | |||||||||||
UniProt ID | Q8IWA5 | ||||||||||
Protein name | Choline transporter-like protein 2 (Solute carrier family 44 member 2) | ||||||||||
Protein function | [Isoform 1]: Choline/H+ antiporter, mainly in mitochodria (PubMed:10677542, PubMed:20665236, PubMed:23651124, PubMed:33789160). Also acts as a low-affinity ethanolamine/H+ antiporter, regulating the supply of extracellular ethanolamine (Etn) for | ||||||||||
Family and domains |
Pfam
|
||||||||||
Tissue specificity | TISSUE SPECIFICITY: Present in supporting cells of the inner ear (at protein level). {ECO:0000269|PubMed:14973250, ECO:0000269|PubMed:20665236}.; TISSUE SPECIFICITY: [Isoform 3]: Expressed in inner ear vestibular tissue. {ECO:0000269|PubMed:20665236}. | ||||||||||
Sequence |
|
||||||||||
Sequence length | 706 | ||||||||||
Interactions | View interactions |
Pathways
Pathway information has different metabolic/signaling pathways associated with genes.
|
|||||||||
|
Associated diseases
Disease information provided by ClinVar, GenCC, and GWAS databases.
|
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||
|